Complete response of ductal carcinoma in situ to neoadjuvant systemic therapy in HER2-positive invasive breast cancer patients: a nationwide analysis

被引：0
|
作者：
Ploumen, R. [1 ,2 ]
Claassens, E. [1 ]
Kooreman, L. [2 ,3 ]
Keymeulen, K. [1 ]
van Kats, M. [4 ]
Gommers, S.
Siesling, S. [6 ,7 ]
van Nijnatten, T. [2 ,5 ]
Smidt, M. [1 ,2 ]
机构：
[1] Maastricht Univ, Surg, Med Ctr, Maastricht, Netherlands
[2] GROW, Sch Oncol & Reprod, Maastricht, Netherlands
[3] Maastricht Univ, Pathol, Med Ctr, Maastricht, Netherlands
[4] Maastricht Univ, Med Oncol, Med Ctr, Maastricht, Netherlands
[5] Maastricht Univ, Radiol & Nucl Med, Med Ctr, Maastricht, Netherlands
[6] Univ Twente, Hlth Technol & Serv Res, Tech Med Ctr, Enschede, Netherlands
[7] Netherlands Comprehens Canc Org, Res & Dev, Utrecht, Netherlands
来源：
EUROPEAN JOURNAL OF CANCER | 2022年 / 175卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1LBA
引用
收藏
页码：S1 / S1
页数：1
相关论文
共 50 条
  • [1] Complete response of ductal carcinoma in situ to neoadjuvant systemic therapy in HER2-positive invasive breast cancer patients: a nationwide analysis
    Ploumen, Roxanne
    Claassens, Eva
    Kooreman, Loes
    Keymeulen, Kristien
    van Kats, Maartje
    Gommers, Suzanne
    Siesling, Sabine
    van Nijnatten, Thiemo
    Smidt, Marjolein
    CANCER RESEARCH, 2023, 83 (05)
  • [2] Pathologic complete response of ductal carcinoma in situ to neoadjuvant systemic therapy in HER2-positive invasive breast cancer patients: a nationwide analysis
    Ploumen, Roxanne A. W.
    Claassens, Eva L.
    Kooreman, Loes F. S.
    Keymeulen, Kristien B. M. I.
    van Kats, Maartje A. C. E.
    Gommers, Suzanne
    Siesling, Sabine
    van Nijnatten, Thiemo J. A.
    Smidt, Marjolein L.
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 201 (02) : 227 - 235
  • [3] Pathologic complete response of ductal carcinoma in situ to neoadjuvant systemic therapy in HER2-positive invasive breast cancer patients: a nationwide analysis
    Roxanne A. W. Ploumen
    Eva L. Claassens
    Loes F. S. Kooreman
    Kristien B. M. I. Keymeulen
    Maartje A. C. E. van Kats
    Suzanne Gommers
    Sabine Siesling
    Thiemo J. A. van Nijnatten
    Marjolein L. Smidt
    Breast Cancer Research and Treatment, 2023, 201 : 227 - 235
  • [4] Pathologic response of ductal carcinoma in situ to neoadjuvant systemic treatment in HER2-positive breast cancer
    Groen, Emma J.
    van der Noordaa, Marieke E. M.
    Schaapveld, Michael
    Sonke, Gabe S.
    Mann, Ritse M.
    van Ramshorst, Mette S.
    Lips, Esther H.
    Peeters, Marie-Jeanne T. F. D. Vrancken
    van Duijnhoven, Frederieke H.
    Wesseling, Jelle
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 189 (01) : 213 - 224
  • [5] Pathologic response of ductal carcinoma in situ to neoadjuvant systemic treatment in HER2-positive breast cancer
    Emma J. Groen
    Marieke E. M. van der Noordaa
    Michael Schaapveld
    Gabe S. Sonke
    Ritse M. Mann
    Mette S. van Ramshorst
    Esther H. Lips
    Marie-Jeanne T. F. D. Vrancken Peeters
    Frederieke H. van Duijnhoven
    Jelle Wesseling
    Breast Cancer Research and Treatment, 2021, 189 : 213 - 224
  • [6] Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy
    Takeo Fujii
    Takahiro Kogawa
    Jimin Wu
    Aysegul A Sahin
    Dian D Liu
    Mariana Chavez-MacGregor
    Sharon H Giordano
    Akshara Raghavendra
    Rushmy K Murthy
    Debu Tripathy
    Yu Shen
    Jose-Miguel Yamal
    Naoto T Ueno
    British Journal of Cancer, 2017, 116 : 509 - 514
  • [7] Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy
    Fujii, Takeo
    Kogawa, Takahiro
    Wu, Jimin
    Sahin, Aysegul A.
    Liu, Dian D.
    Chavez-MacGregor, Mariana
    Giordano, Sharon H.
    Raghavendra, Akshara
    Murthy, Rushmy K.
    Tripathy, Debu
    Shen, Yu
    Yamal, Jose-Miguel
    Ueno, Naoto T.
    BRITISH JOURNAL OF CANCER, 2017, 116 (04) : 509 - 514
  • [8] Comment on 'Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy'
    Altundag, Kadri
    BRITISH JOURNAL OF CANCER, 2017, 116 (08) : e10 - e10
  • [9] Comment on ‘Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy’
    Kadri Altundag
    British Journal of Cancer, 2017, 116 : e10 - e10
  • [10] Preoperative systemic inflammation response index: Clinicopathologic predictor of pathological complete response in HER2-positive breast cancer patients receiving neoadjuvant systemic therapy
    Wu, Hong-Yu
    Lin, Chin-Yao
    Tzeng, Yen-Dun
    Hung, Chih-Chiang
    Liu, Shiuh-Inn
    Yin, Chun-Hao
    Chen, Jin-Shuen
    Chen, Yao-Shen
    Yang, Jie-Ru
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2024, 87 (02) : 226 - 235
12345